FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1523081000168102: bupivacaine hydrochloride 20 mg / 4 mL + glucose 320 mg / 4 mL intrathecal injection, 4 mL ampoule (medicinal product unit of use)

Status: current, Defined. Date: 31-Jan 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4519591000168113 bupivacaine hydrochloride 20 mg / 4 mL + glucose 320 mg / 4 mL intrathecal injection, 4 mL ampoule (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4519601000168118 bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule en Synonym Active Case sensitive Australian Medicines Terminology module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule Is a bupivacaine hydrochloride 0.5% (20 mg/4 mL) injection, ampoule false Inferred relationship Some
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule Is a bupivacaine + glucose true Inferred relationship Some
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule has manufactured dose form intrathecal injection true Inferred relationship Some
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule has intended active ingredient bupivacaine true Inferred relationship Some 1326495607
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule has Australian BoSS bupivacaine hydrochloride true Inferred relationship Some 1326495607
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule has unit of use ampoule true Inferred relationship Some 805154527
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule has intended active ingredient glucose true Inferred relationship Some 1030845413
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule has Australian BoSS glucose true Inferred relationship Some 1030845413
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule Is a bupivacaine hydrochloride 0.5% (20 mg/4 mL) intrathecal injection, ampoule true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Bupivacaine Spinal Heavy (BNM) intrathecal injection, 4 mL ampoule Is a True bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule Inferred relationship Some
bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, 10 x 4 mL ampoules has MPUU True bupivacaine hydrochloride 0.5% (20 mg/4 mL) + glucose 320 mg/4 mL intrathecal injection, ampoule Inferred relationship Some 1855089428

Reference Sets

Medicinal product unit of use reference set

Back to Start